Rising erythrocyte sedimentation rate during several years before diagnosis can be a predictive factor in 70% of renal cell carcinoma patients. The benefit of knowing subject-based reference values

被引:7
作者
Iversen, OH
Roger, M
Solberg, HE
Wetteland, P
机构
[1] UNIV OSLO,INST PATHOL,N-0027 OSLO,NORWAY
[2] UNIV OSLO,DEPT CLIN CHEM,N-0027 OSLO,NORWAY
[3] UNIV OSLO,RIKSHOSP,N-0027 OSLO,NORWAY
关键词
disease-predictive power of ESR; ESR (erythrocyte sedimentation rate); RCC (renal cell carcinoma);
D O I
10.1046/j.1365-2796.1996.30195852000.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. A diagnosis of renal cell carcinoma (RCC) early enough for potentially curative surgery is difficult. We wanted to establish whether the erythrocyte sedimentation rate (ESR) in RCC patients had begun to rise before the appearance of any symptoms or signs and, if so, when. Design, A retrospective study of the evolution of the ESR in 236 randomly selected RCC patients during several years before diagnosis, comparing the results with previously obtained population-based control values, Results. It is generally held that RCC patients have a high ESR at diagnosis. In our material, however, 29.7% of the RCC cases had an ESR that at this time was at or below the population-based upper reference limit; it had not increased significantly, neither with time before diagnosis, nor with age. In 70.3% of RCC patients the ESR was increased and had been significantly rising for up to 6 years or more before diagnosis. This had not been adequately responded to, probably because the physicians lacked knowledge of the patients' baseline ESR, and because none of the prediagnostic readings had been above the population-based reference limit. Conclusions, Systematic ESR graphic recordings over time will enable a physician to determine each individual's baseline value, and hence note any continuously rising trend, which should lead to further investigations, e.g. an ultrasound kidney examination. This may provide an early clue to many otherwise non-symptomatic RCC cases. It is time for a reappraisal of the predictive value of the ESR to discover early RCC, and possibly other diseases as well.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 26 条
  • [1] Armitage P., 1971, STAT METHODS MED RES
  • [2] BLAY JY, 1992, CANCER RES, V52, P3317
  • [3] BOTTIGER LE, 1982, ACTA MED SCAND, V212, P353
  • [4] BOTTIGER LE, 1960, ACTA MED SCAND, V167, P443
  • [5] BOYD JC, 1982, CLIN CHEM, V28, P259
  • [6] *CANC REG NORW, 1995, CANC NORW 1992
  • [7] CHERUKURI S V, 1977, Urology, V10, P93, DOI 10.1016/0090-4295(77)90001-2
  • [8] CHISHOLM G D, 1971, British Journal of Urology, V43, P687, DOI 10.1111/j.1464-410X.1971.tb12089.x
  • [9] CHISHOLM GD, 1974, ANN ROY COLL SURG, V55, P21
  • [10] Confusing clinical manifestations of malignant renal neoplasms
    Creevy, CD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1935, 55 (06) : 895 - 916